Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer
As an emerging technology in precision medicine, the patient-derived organoid (PDO) technology has been indicated to provide novel modalities to judge the sensitivity of individual tumors to cancer drugs. In this work, an in vitro model of colorectal cancer (CRC) was established using the PDO cultur...
Saved in:
Published in | ACS biomaterials science & engineering Vol. 8; no. 8; pp. 3515 - 3525 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
08.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!